GNH USA

Europe — EMA

Immunine

GNH USA supplies Immunine (Human Coagulation Factor IX), a Factor IX concentrate for hemophilia B and acquired factor IX deficiency.

Human Coagulation Factor Ix

Request sourcing

1
Pack/s

What is Human Coagulation Factor Ix?

Human Coagulation Factor IX, the active ingredient in Immunine, is a Factor IX concentrate presented as a solution for injection for intravenous use. It treats hemophilia B and acquired factor IX deficiency in patients with deficient coagulation factor IX.

GNH USA supplies Immunine as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals worldwide.

What is Human Coagulation Factor Ix used for?

Immunine is a Factor IX concentrate used to replace deficient clotting factor in the intrinsic pathway of the coagulation cascade.

Hemophilia B: restores normal clotting and reduces bleeding episodes. Acquired factor IX deficiency: provides necessary factor IX to support hemostasis.

What are the side effects of Human Coagulation Factor Ix?

Common Side Effects: - Infusion‑related reactions (e.g., flushing, chills) - Headache - Fever - Nausea - Arthralgia - Mild rash

Serious or Rare Side Effects: - Anaphylactic or severe allergic reactions - Development of factor IX inhibitors (antibodies) - Thrombotic events - Viral transmission risk from plasma‑derived product - Hemolysis - Renal impairment

What precautions apply to Human Coagulation Factor Ix?

Immunine requires careful clinical monitoring and adherence to handling standards.

Dose individualized: dosing is based on factor IX activity levels and patient response. Monitor for inhibitor development: regular testing for anti‑factor IX antibodies is recommended. Assess for viral infections: screen donors and recipients for blood‑borne pathogens. Use aseptic technique: ensure sterile preparation and administration to avoid contamination. Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

What does Human Coagulation Factor Ix interact with?

Immunine may interact with other agents affecting coagulation.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin, heparin): may counteract the clotting effect of factor IX. - Activated prothrombin complex concentrates: combined use increases thrombosis risk.

Moderate Interactions (Monitor Closely): - Antifibrinolytics (e.g., tranexamic acid): may enhance clot stability, monitor for excessive clotting. - Immunosuppressants: could influence inhibitor formation, require observation. - Live vaccines: timing may need adjustment to avoid interference with immune response.

Frequently asked questions

What is Immunine used for?+
Immunine is a Factor IX concentrate indicated for the treatment and prophylaxis of bleeding in patients with hemophilia B (inherited factor IX deficiency) and for individuals with acquired factor IX deficiency. It replaces the missing clotting protein to help restore normal hemostasis.
How does Human Coagulation Factor IX work in Immunine?+
Human Coagulation Factor IX supplied by Immunine binds to activated factor X on platelet surfaces, forming the intrinsic tenase complex. This complex accelerates the conversion of prothrombin to thrombin, leading to fibrin clot formation and effectively correcting the clotting defect caused by factor IX deficiency.
What is the usual dose of Immunine?+
The dose of Immunine is individualized by the prescribing clinician based on the patient’s factor IX activity level, weight, severity of bleeding, and clinical response. Exact dosing regimens are determined by the treating physician and are not standardized in public information.
Is Immunine safe to use during pregnancy or breastfeeding?+
The safety of Immunine in pregnancy or while breastfeeding has not been definitively established. Healthcare providers should weigh the potential benefits against any unknown risks and consider alternative therapies if appropriate.
How do I order Immunine from GNH USA?+
To order Immunine, submit an enquiry on the product page at gnh-usa.com specifying the required quantity. GNH USA works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, cold‑chain shipping details, and necessary import documentation.
How does Immunine compare with other factor IX products?+
Immunine is a plasma‑derived Factor IX concentrate, similar in activity to recombinant factor IX products. While recombinant forms avoid plasma‑derived pathogen risk, both provide comparable efficacy in correcting factor IX deficiency. Choice between them depends on physician preference, patient tolerance, and supply considerations.
What are the storage and handling requirements for Immunine?+
Immunine must be stored refrigerated at 2‑8 °C, protected from light, and should never be frozen or shaken. Keep the vial in its original packaging until use to maintain stability and sterility.
How is Immunine administered?+
Immunine is supplied as a sterile solution for injection and is administered intravenously. The infusion rate and volume are determined by the prescribing clinician, and the product should be given using aseptic technique in a clinical setting.
What are the most serious risks associated with Immunine?+
Serious risks include the development of inhibitory antibodies against factor IX, severe allergic or anaphylactic reactions, thrombotic events, and the theoretical risk of transmission of blood‑borne pathogens despite rigorous donor screening and viral inactivation processes.
Who should not use Immunine?+
Immunine should be avoided in patients with known hypersensitivity to any component of the product, in those who have previously developed inhibitors to factor IX, or in individuals with uncontrolled active thrombosis. Clinical judgment is required for each case.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Human Coagulation Factor Ix
Route
Intravenous Use
Manufacturer
Baxalta Innovations Gmbh
Origin
EU

Related products